Neoadjuvant chemotherapy for advanced ovarian cancer

International Journal of Gynecological Cancer

Volumn 6, Issue 5, 1996, Pages 356-361

  Surwit, E ^a,b   Childers, J ^a   Atlas, I ^a   Nour, M ^a   Hatch, K ^a   Hallum, A ^a   Alberts, D ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Breast Center of Southern Arizona   (United States)

Author keywords

CA125; chemosensitive; CT scan; debulking; neoadjuvant; ovarian

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASCITES; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029738072     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1996.06050356.x     Document Type: Article

References (19)

1. Lawton FG, Redman CW, Luesly DM, Chan KK, Blackledge G. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer. Obstet Gynecol 1989; 73: 61-5.
2. Chambers JT, Chambers SK, Voynick IM, Schwartz PE. Neoadjuvant chemotherapy in stage X ovarian cancer. Gynecol Oncol 1990; 37: 327-31.
3. Jacob JH, Gershenson DM, Morris M, Copeland L, Burke TW, Wharton JT. Neoadjuvant chemotherapy and interval debulking for advanced ovarian cancer. Gynecol Oncol 1991; 42: 146-50.
4. Lim JTW, Green JA. Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma. Clin Oncol 1993; 5: 198-202.
5. Schwartz PE, Chambers JT, Makuch R. Neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol 1994; 53: 33-7.
6. Van der Burg ME, Van Lent M, Buyse M, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 1995; 32: 629-34.
7. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993; 11: 166-72.
8. Calvert AH, Newell DR, Gumbrell LA, O'Rielly S. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7: 1748-56.
9. Heintz AP, Hacker NF, Berek JS, Rose TP, Munoz AK, Lagasse LD. Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 1986; 67: 783-8.
10. Chen SS, Bochner R. Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma. Gynecol Oncol 1985; 20: 190-5.
11. Hunter RW, Alexander ND, Soutter WP. Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 1992; 53: 326-30.
12. Guidozzi F, Ball JH. Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 1994; 53: 326-30.
13. Liu PY, Alberts D, Frederico M, et al. CA125 concentration eight weeks after treatment initiation independently predicts survival in patients with advanced epithelial ovarian cancer: A Southwest Oncology Group (SWOG) study. Proc Soc Clin Oncol, vol 14, March 1995.
14. Hogberg T. Primary surgery in ovarian cancer: Current opinions. Ann Med 1995; 27: 95-100.
15. Potter ME, Partridge EE, Hatch KD, Soong SJ, Austin JM, Shingleton HM. Primary surgical therapy of ovarian cancer: How much and when. Gynecol Oncol 1991; 40: 195-200.
16. Redman JR, Petroni GR, Saigo PE, Geller NL, Hakes TB. Prognostic factors in advanced ovarian cancer. J Clin Oncol 1986; 4: 515-23.
17. Heintz AP, Van Oosterom AT, Baptist J, et al. The treatment of advanced ovarian carcinoma (1): Clinical variables associated with prognosis. Gynecol Oncol 1988; 30: 347-58.
18. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983; 61: 413-20.
19. Hoskins WJ. Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer 1993; 71: 1534-40.